Treatment of Macrolide-resistant Mycoplasma Pneumoniae (NCT03530319) | Clinical Trial Compass
UnknownNot Applicable
Treatment of Macrolide-resistant Mycoplasma Pneumoniae
Taiwan100 participantsStarted 2018-11-10
Plain-language summary
A randomized clinical trial comparing treatment effectiveness of azithromycin and doxycycline for pediatric Mycoplasma pneumonia.
Who can participate
Age range1 Year – 18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Children aged 1-18 years, admitted due to lower respiratory tract infections. Mycoplamsa pneumonia is diagnosed.
* The diagnosis is made within 72 hours after fever onset.
* The patient and his/her guardians are willing to participate the study and able to follow the instruction.
Exclusion Criteria:
* Patients who have already taken macrolides, tetracyclines, or fluoroquinolones.
* Patient's with congenital or acquired immunodeficiency.
* Severe patients who needs ICU care.
* Patients or their guardians who are not willing to participate in the study.